Human vs. Bovine Milk-based Fortifiers for Very Preterm Infants: A Comparative Analysis
This observational study compares the effects of human and bovine milk-based fortifiers in very preterm infants, focusing on the occurrence of a composite of necrotizing enterocolitis (NEC), culture-proven late-onset sepsis, mortality, and the percentage of infants with an interruption in enteral feeding.
Data Collection
Collected from past medical records and data - RetrospectiveNeonatal Sepsis+14
+ Death
+ Digestive System Diseases
Other
Utilizing specific methods not covered by standard models in order to address unique research questions.Summary
Study start date: October 1, 2014
Actual date on which the first participant was enrolled.This study focuses on very preterm infants who weigh less than expected at birth. While mother's milk is the best food for these infants, it often doesn't provide all the nutrients they need. To fill this gap, doctors usually add nutrient fortifiers made from cow's milk. However, there's growing interest in using fortifiers made from human milk instead, as they might be safer and healthier. This study aims to compare the effects of using human milk-based fortifiers (HMBF) and cow's milk-based fortifiers (BMBF) on the health of these preterm infants. It looks at data from two previous studies where infants were fed either with HMBF or BMBF. The study's goal is to understand if using HMBF can lower the risk of death, severe illness, or major feeding interruptions during the infants' hospital stay. In this study, participants from the two previous trials were either fed with HMBF or BMBF. The feeding intervention started as soon as the infants were assigned to one of these two groups. One of the studies allowed for personalized fortification based on milk analysis, while the other used standard fortification. The feeding intervention continued until the infants reached a certain age, were discharged, or started eating solid food. The study measured two main outcomes. First, it checked if the infants developed a serious digestive problem called NEC, a severe infection known as late-onset sepsis, or if they passed away. Second, it recorded if there were any interruptions in the infants' feeding that lasted for 12 hours or more, or if the feeding volume was reduced by more than half over the same time period.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.355 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Umeå University
Umeå, Sweden